Lindis Blood Care GmbH

📍 Hennigsdorf, Germany🗓 Founded 2018👥 5 employees💰 Last funded Jan 2024
Medical Equipment Manufacturing🌐 lindis-bloodcare.com
Website LinkedIn
Lindis Blood Care is a medical technology company aiming to set the new gold standard in oncological blood management by combining currently used filter technologies with its trifunctional antibody to reliably remove EpCAM-positive cancer cells from intraoperative blood with its medical device CATUVAB®. CATUVAB® has the potential of making autologous blood transfusion possible during oncological surgeries, by ensuring that no tumor cells with metastasizing potential will be given back to the patient. Thereby making autologous blood transplant accessible to cancer patients while eliminating the negative side effects associated with allogenic blood transfusions.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Lindis Blood Care GmbH?
Lindis Blood Care GmbH has 1 investors on record on gritt.io and 1 late-stage investors.
When did Lindis Blood Care GmbH last raise funding?
The most recent investment in Lindis Blood Care GmbH recorded on gritt.io was in January 2024.
When was Lindis Blood Care GmbH founded?
Lindis Blood Care GmbH was founded in 2018.
What industry is Lindis Blood Care GmbH in?
Lindis Blood Care GmbH operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Lindis Blood Care GmbH based?
Lindis Blood Care GmbH is headquartered in Hennigsdorf, Germany.